Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
Am J Cardiovasc Drugs. 2012 Jun 1;12(3):157-63. doi: 10.2165/11598990-000000000-00000.
The bark of the tree Terminalia arjuna (Roxb.) is widely used in Indian medicine (Ayurveda) for various cardiovascular ailments. The bark has been reported to contain several bioactive compounds. Many experimental studies have reported its antioxidant, anti-ischemic, antihypertensive, and antihypertrophic effects, which have relevance to its therapeutic potential in cardiovascular diseases in humans. Several clinical studies have reported its efficacy mostly in patients with ischemic heart disease, hypertension, and heart failure. However, a major shortcoming in all these experimental and clinical studies is the absence of phytochemical standardization of the extracts. In addition, many clinical studies are poor in terms of design and methods used for generating safety data. This review discusses how to address all these issues for a scientific validation of this medicinal plant.
这种树的树皮 Terminalia arjuna(Roxb.)在印度医学(阿育吠陀)中被广泛用于治疗各种心血管疾病。据报道,这种树皮含有几种生物活性化合物。许多实验研究报告了其抗氧化、抗缺血、降压和抗心肌肥厚的作用,这与其在人类心血管疾病中的治疗潜力有关。几项临床研究报告了其疗效,主要是在缺血性心脏病、高血压和心力衰竭患者中。然而,所有这些实验和临床研究的一个主要缺点是提取物缺乏植物化学标准化。此外,许多临床研究在设计和安全性数据生成方面都存在缺陷。这篇综述讨论了如何解决所有这些问题,以对这种药用植物进行科学验证。